Cullinan Oncology Inc To Provide CLN-081 Clinical Update Webinar Call Transcript
Good morning, everyone, and welcome to the Cullinan Oncology webinar to discuss updated clinical data for our lead program, CLN-081. Earlier this morning, we issued a press release providing an overview of the data, which can be accessed on the Investors section of our website at investors.cullinanoncology.com.
During today's presentation, management will be making certain forward-looking statements, as outlined on this slide. These forward-looking statements are based on current information, assumptions and expectations that are subject to change and involve a number of risks and uncertainties, which may cause actual results to differ materially from those contained in such forward-looking statements. These risks are described more fully in the company's filings made with the Securities and Exchange Commission, including our annual report on Form 10-K. You are cautioned not to place any undue reliance on these forward-looking statements, and we disclaim any obligation to update such statements.
In addition, this call contains time-sensitive information, accurate only as of the date
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |